Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.23.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid In Capital
Accumulated Deficit
Total Akoustis Technologies, Inc. Equity
Noncontrolling Interest
Total
Balance at Jun. 30, 2021 $ 51 $ 265,130 $ (147,771) $ 117,410 $ 117,410
Balance (in Shares) at Jun. 30, 2021 51,236          
Common stock issued for cash, net of issuance costs $ 3 25,627 25,630 25,630
Common stock issued for cash, net of issuance costs (in Shares) 3,644          
Stock-based compensation $ 1 7,753 7,754 7,754
Stock-based compensation (in Shares) 662          
ESPP purchases $ 1 311 312 312
ESPP purchases (in Shares) 53          
Common stock issued for exercise of warrants 67 67 67
Common stock issued for exercise of warrants (in Shares) 21          
Common stock issued for exercise of options 369 369 369
Common stock issued for exercise of options (in Shares) 72          
Noncontrolling interest acquired 7,523 7,523
Common stock issued in acquisition 2,297 2,297   2,297
Common stock issued in acquisition (in Shares) 263          
Net loss (42,799) (42,799) (121) (42,920)
Balance at Mar. 31, 2022 $ 56 301,554 (190,570) 111,040 7,402 118,442
Balance (in Shares) at Mar. 31, 2022 55,951          
Balance at Dec. 31, 2021 $ 55 291,969 (175,884) 116,140 7,528 123,668
Balance (in Shares) at Dec. 31, 2021 54,660          
Common stock issued for cash, net of issuance costs $ 1 6,840 6,841 6,841
Common stock issued for cash, net of issuance costs (in Shares) 1,158          
Stock-based compensation 2,506 2,506 2,506
Stock-based compensation (in Shares) 69          
Common stock issued for exercise of warrants 10 10 10
Common stock issued for exercise of warrants (in Shares) 12          
Common stock issued for exercise of options 229 229 229
Common stock issued for exercise of options (in Shares) 52          
Noncontrolling interest acquired 13 13
Net loss (14,686) (14,686) (139) (14,825)
Balance at Mar. 31, 2022 $ 56 301,554 (190,570) $ 111,040 7,402 118,442
Balance (in Shares) at Mar. 31, 2022 55,951          
Balance at Jun. 30, 2022 $ 57 310,170 (206,798)   103,429
Balance (in Shares) at Jun. 30, 2022 57,079          
Common stock issued for cash, net of issuance costs $ 13 32,013   32,026
Common stock issued for cash, net of issuance costs (in Shares) 12,545          
Stock-based compensation $ 1 7,453   7,454
Stock-based compensation (in Shares) 904          
ESPP purchases 288   288
ESPP purchases (in Shares) 89          
Common stock issued in acquisition $ 1 1,689   1,690
Common stock issued in acquisition (in Shares) 606          
Common stock issued in payment of note interest 1,364   1,364
Common stock issued in payment of note interest (in Shares) 402          
Net loss (45,792)   (45,792)
Balance at Mar. 31, 2023 $ 72 352,977 (252,590)   100,459
Balance (in Shares) at Mar. 31, 2023 71,625          
Balance at Dec. 31, 2022 $ 58 316,065 (237,045)     79,078
Balance (in Shares) at Dec. 31, 2022 58,161          
Common stock issued for cash, net of issuance costs $ 13 32,013     32,026
Common stock issued for cash, net of issuance costs (in Shares) 12,545          
Stock-based compensation $ 0 3,210     3,210
Stock-based compensation (in Shares) 313          
Common stock issued in acquisition $ 1 1,689     1,690
Common stock issued in acquisition (in Shares) 606          
Net loss (15,545)     (15,545)
Balance at Mar. 31, 2023 $ 72 $ 352,977 $ (252,590)   $ 100,459
Balance (in Shares) at Mar. 31, 2023 71,625